hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06337058 id: KSUHULYAKAMALAK001 briefTitle: Motivational Interviews With Women Experiencing Sexual Dysfunction During Menopause Period overallStatus: COMPLETED date: 2020-06-15 date: 2021-06-15 date: 2022-12-15 date: 2024-03-29 date: 2024-03-29 name: Hülya KAMALAK class: OTHER briefSummary: The aim of this study is to evaluate the effect of motivational interviews with women who experience sexual dysfunction during menopause on sexual quality of life and self-efficacy.The population of the study consisted of menopausal women who applied to the gynecology outpatient clinic of Kahramanmaraş Sütçü İmam University Health Practice and Research Hospital. It was calculated as 164 women (82 experimental, 82 control).In data collection, 'Personal Information Form (EK- )', 'Arizona Sexual Experiences Scale (ACYÖ) (EK- )', 'Sexual Quality of Life Scale-Female (SIQQ-F) (EK-)' and 'Sexual Self-Efficacy Scale' (Annex- )' was used. conditions: Sexual Dysfunction studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 164 type: ACTUAL name: Experimental group (motivational interview) measure: Arizona Sexual Experiences Scale - Female Version Questionnaire (ASEX-F) measure: Arizona Sexual Experiences Scale - Female Version Questionnaire (ASEX-F) measure: Sexual Quality of Life-Female Questionnaire (SQOL-F) measure: Sexual Quality of Life-Female Questionnaire (SQOL-F) measure: Sexual Self-Efficacy Scale (SSES) measure: Sexual Self-Efficacy Scale (SSES) sex: FEMALE stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Kahramanmaras Sutçu Imam University city: Kahramanmaraş country: Turkey lat: 37.5847 lon: 36.92641 hasResults: False
nctId: NCT06337045 id: AF-rehab briefTitle: Atrial Fibrillation, Prevention and Rehabilitation overallStatus: COMPLETED date: 2019-02-01 date: 2020-06-30 date: 2020-06-30 date: 2024-03-29 date: 2024-03-29 name: Odense University Hospital class: OTHER name: Department of Cardiology, Odense University Hospital, Odense, Denmark. name: Health Center, Municipality of Svendborg, Svendborg, Denmark. name: Department of Internal Medicine & Emergency Department, Svendborg Hospital, Odense University Hospital, Svendborg, Denmark. name: The Danish Heart Association, Funen, and local committee in Svendborg, Denmark briefSummary: Evidence shows that people with atrial fibrillation (AF) can benefit from prevention and rehabilitation interventions related to quality of life, lowered anxiety, etc. In this study, a complex prevention and rehabilitation intervention for people with AF was carried out in a Health Center at a Danish municipality in cooperation with the cardiology department at Svendborg Hospital. The study was designed as a feasibility study, with data gathered systematically including focus group interviews and quantitative patient reported outcomes. People with AF were included at the hospital. Eligible participants were offered intervention in the Health Center. Interventions, in accordance with present international guidelines, consisted of physical exercise, patient education, psychosocial support and consultations with health professionals as well as risk factor management. Also, medicinal yoga (MediYoga) were chosen to be part of the intervention due to promising research results within AF. All interventions were optional and based on needs assessment and preferences.
The hypothesis was that the complex prevention and rehabilitation intervention was feasible in a municipality-based set-up, and was well received by people with AF and may contribute to better outcomes in terms of HRQoL, anxiety and depression. conditions: Atrial Fibrillation conditions: Prevention conditions: Rehabilitation studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: Eligible participants were diagnosed with AF at the hospital and had symptomatic AF rated by the modified European Heart Rhythm Association (mEHRA) score ≥2B. If the patient was eligible based on the mEHRA-score, at least one of the following risk factors had to be present: hypertension, diabetes, obesity, smoking, excessive alcohol consumption, physical inactivity, sleep apnoea, anxiety, depression, or mental vulnerability. primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 50 type: ACTUAL name: Complex prevention and rehabilitation intervention measure: HeartQoL measure: The hospital anxiety and depression scale (HADS) measure: Experience of participating, experiences needs and preferences of interventions measure: Feasibility of collecting patient reported outcomes (PROMs). The PROMs was the HeartQoL and the hospital anxiety and depression scale. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Department of Cardiology, Odense University Hospital city: Odense state: Region Of Southern Denmark zip: 5000 country: Denmark lat: 55.39594 lon: 10.38831 facility: Health Center, Municipality Svendborg city: Svendborg state: Region Of Southern Denmark zip: 5700 country: Denmark lat: 55.05982 lon: 10.60677 hasResults: False
nctId: NCT06337032 id: GS-US-380-6684 briefTitle: A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments overallStatus: NOT_YET_RECRUITING date: 2024-09 date: 2034-03 date: 2034-03 date: 2024-03-29 date: 2024-03-29 name: Gilead Sciences class: INDUSTRY briefSummary: The goal of this clinical study is to provide continued access to the study drug(s) to children and adolescents with human immunodeficiency virus type 1 (HIV-1) who completed their participation in an applicable parent study and to monitor for adverse events.
* To evaluate the safety of the study drug(s) in participants with HIV-1. conditions: HIV-1-infection studyType: INTERVENTIONAL phases: PHASE4 allocation: NON_RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 350 type: ESTIMATED name: F/TAF (High Dose Tablet) name: F/TAF (Low Dose Tablet) name: F/TAF (Lowest Dose Tablet) name: F/TAF (High Dose TOS) name: F/TAF (Low Dose TOS) name: F/TAF (Lowest Dose TOS) name: E/C/F/TAF name: E/C/F/TAF (Low Dose) name: Cobicistat (High Dose) name: Cobicistat (Low Dose) name: Cobicistat (TOS) name: B/F/TAF (High Dose) name: B/F/TAF (Low Dose) name: B/F/TAF (High Dose TOS) name: B/F/TAF (Low Dose TOS) name: B/F/TAF (Lowest Dose TOS) name: 3rd ARV Agent name: Nucleos(t)ide reverse transcriptase inhibitors (NRTI) name: ATV name: DRV name: Lopinavir Boosted with ritonavir (LPV/r) measure: Number of Eligible Participants Who Have Received Access to the Study Drug(s) in the Study measure: Percentage of Participants Experiencing Treatment-Emergent Adverse Events (TEAEs) sex: ALL minimumAge: 1 Month maximumAge: 18 Years stdAges: CHILD stdAges: ADULT hasResults: False
nctId: NCT06337006 id: SÜKAEK 2023/14/1 briefTitle: Laryngeal Mask Airway Failure in Pediatric Patients overallStatus: RECRUITING date: 2023-09-15 date: 2024-04-15 date: 2024-05-15 date: 2024-03-29 date: 2024-03-29 name: Samsun University class: OTHER briefSummary: There are a significant number of studies identifying risk factors for misplacement of LMAs. However, despite objective data indicating that tracheal intubation is performed inappropriately, such as air leaks, high air pressures, insufficient lung ventilation and single lung ventilation, which are easily identified after tracheal intubation, there are no objective data to define the misplacement of LMAs, which are increasingly used especially in short surgical procedures.
The aim of the study was to describe unsuccessful LMA placement in pediatric patients with objective data. conditions: Airway Management studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: PROSPECTIVE count: 50 type: ESTIMATED name: Placement of the laryngeal mask airway measure: Evaluation of the success of placement of the laryngeal mask airway sex: ALL minimumAge: 2 Years maximumAge: 12 Years stdAges: CHILD facility: Samsun University status: RECRUITING city: Samsun state: Canik zip: 55090 country: Turkey name: OZGUR KOMURCU, 1 role: CONTACT phone: 90 505 5273180 email: zgrkom@gmail.com name: Hatice SELCUK KUSDERCİ role: PRINCIPAL_INVESTIGATOR lat: 41.27976 lon: 36.3361 hasResults: False
nctId: NCT06336993 id: liuxianguiji briefTitle: Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP overallStatus: COMPLETED date: 2022-01-01 date: 2023-06-16 date: 2023-12-15 date: 2024-03-29 date: 2024-03-29 name: Zhejiang Provincial Tongde Hospital class: OTHER briefSummary: The aim of this randomized controlled trial was to explore the clinical efficacy and safety of HXTL in the treatment of NSLBP based on TCM principles and to compare the clinical outcomes of different syndromes of NSLBP with celecoxib.In this study, 80 patients with NSLBP were recruited and randomly grouped to use TCM compound and celeoxib respectively for intervention. The pain status and lumbar function use scale of patients were scored before intervention, 1 week, 2 weeks and 3 weeks after intervention, and the adverse reactions of patients after medication were recorded, and the clinical efficacy of the two groups of patients was compared finally. conditions: Low Back Pain studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 71 type: ACTUAL name: herbal compound name: Celecoxib measure: Visual Analogue Scale measure: Oswestry disability index measure: Japanese Orthopaedic Association Scores measure: the adverse reactions of digestive or other system sex: ALL minimumAge: 20 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Tongde Hospital city: Hangzhou state: Zhejiang zip: 310000 country: China lat: 30.29365 lon: 120.16142 hasResults: False
nctId: NCT06336980 id: 31021 briefTitle: Creating Welcoming Faith Communities for People With Serious Mental Illnesses overallStatus: RECRUITING date: 2024-01-22 date: 2025-12 date: 2025-12 date: 2024-03-29 date: 2024-03-29 name: Temple University class: OTHER name: National Institute on Disability, Independent Living, and Rehabilitation Research briefSummary: The goal of this intervention study is to test a behavioral intervention to increase inclusionary practices toward individuals with serious mental illness in faith communities. The main questions it aims to answer are:
Congregations will be asked to create an inclusion committee that will then work on developing systems and changing congregational practices to become more inclusive. All congregation members will be invited to a half-day training that will provide information on mental illness and inclusion, and will provide tips and strategies when they encounter situations or behaviors that are less familiar to them. All congregation members will be given the opportunity to participate in a survey about congregational practices. conditions: Other studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: OTHER masking: NONE count: 700 type: ESTIMATED name: Increasing Inclusionary Practices in Faith Communities measure: Inclusionary practices measure: Indicators of Welcome measure: Mental Health Knowledge Questionnaire measure: Social Distance Scale measure: Community Attitudes Toward the Mentally Ill measure: Reported and Intended Behavior Scale measure: Sense of Belonging Scale measure: University of California Los Angeles Loneliness Scale measure: Lerman Quality of Life Interview sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Temple Univeristy status: RECRUITING city: Philadelphia state: Pennsylvania zip: 19121 country: United States name: Crystal Slanzi, PhD role: CONTACT email: crystal.slanzi@temple.edu lat: 39.95233 lon: -75.16379 hasResults: False
nctId: NCT06336967 id: 855282 briefTitle: Testing a Wellness App for First Responders, Military Personnel and Veterans overallStatus: NOT_YET_RECRUITING date: 2024-04-08 date: 2024-09-01 date: 2026-01-01 date: 2024-03-29 date: 2024-04-08 name: University of Pennsylvania class: OTHER name: Nlyten Corp briefSummary: The purpose of the research study is to trial a smart phone application, the GUIDE App, to better understand its impact on social connectedness, personal growth and mental health/wellness among first responders, soldiers, and veterans. The research team will also investigate workplace metrics (e.g., engagement and burnout), implementation outcomes and technical merit. The investigators plan to run a three-armed randomized waitlist pilot feasibility trial with up to 150 participants. conditions: Mental Health Wellness studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 150 type: ESTIMATED name: GUIDE measure: PERMA-Profiler Overall Wellbeing Score measure: Patient Health Questionnaire for depression symptoms (PHQ-8) measure: Generalized Anxiety Disorder (GAD-7) measure: WHO Well-being Index (WHO-5) measure: Personal Wellbeing Score (PWS) measure: Difficulties in Emotion Regulation Scale Short Form (DERS-SF) measure: Positive Emotion (Positive emotion subscale of the PERMA-Profiler) measure: Social Connectedness (Engagement and Relationship subscales of PERMA-Profiler) measure: Social Connectedness (Number of posts/comments in the app) measure: Personal Growth (Meaning and Accomplishment subscales of the PERMA-Profiler) measure: Personal Growth (Total GUIDE lessons and courses completed) measure: Utrecht Work Engagement Scale (UWES-17) measure: Maslach Burnout Inventory (MBI) measure: Job Retention (Employment status) measure: Feasibility of Intervention Measure (FIM) measure: Acceptability of Intervention Measure (AIM) measure: Intervention Appropriateness Measure (IAM) measure: System Usability Scale (SUS) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Pennsylvania city: Philadelphia state: Pennsylvania zip: 19146 country: United States lat: 39.95233 lon: -75.16379 hasResults: False
nctId: NCT06336954 id: MA-NSCLC-#-037 briefTitle: Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure overallStatus: NOT_YET_RECRUITING date: 2024-03-30 date: 2024-07-31 date: 2026-12-31 date: 2024-03-29 date: 2024-03-29 name: Second Affiliated Hospital of Xi'an Jiaotong University class: OTHER briefSummary: This prospective, single-arm trial explores the efficacy of Adibelimab monoclonal antibody combined with Famitinib and chemotherapy in treating locally advanced or metastatic NSCLC patients with negative driver genes who have progressed after PD-1 monoclonal antibody and chemotherapy treatment. The study focuses on assessing progression-free survival (PFS) in 40 participants. Key objectives include evaluating PFS and understanding the progression patterns post-first-line immunotherapy, with an interest in whether switching from PD-1 to PD-L1 inhibitors can overcome immune resistance. conditions: Non Small Cell Lung Cancer studyType: INTERVENTIONAL phases: PHASE2 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 40 type: ESTIMATED name: Adibelimab measure: Progression-free survival time (PFS) measure: Objective Response Rate measure: Duration of Response measure: Overall Survival measure: Treatment-Related Adverse Events sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06336941 id: 32822 briefTitle: "Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON) acronym: HOUSTON overallStatus: RECRUITING date: 2018-06-07 date: 2025-12-31 date: 2030-12-31 date: 2024-03-29 date: 2024-03-29 name: University of Pisa class: OTHER briefSummary: Oral diseases are currently diagnosed by means of clinical examination and supported by surgical biopsy procedures. In particular, daily oral medicine practice is lacking the use of a routine diagnostic support to the visualization of anatomical structures located beyond the mucosal surface. Considering the growing interest in minimally invasive diagnosis, the possibility of having an imaging technique dedicated to the investigation of oral soft tissues and their alterations may be instrumental to support the clinical diagnosis. Therefore, attempts to introduce conventional ultrasonography (US) to the diagnostic work-up of pathological conditions of the head and neck have been done, exploiting the unique features of this technique in terms of limited invasive- ness, repeatability, and cost efficiency.
In the literature, both extraoral and intraoral applications of US have been reported. Extraoral applications mainly focus on the characterization of oral and maxillofacial swellings of various origin, while intraoral applications mostly involve the study of malignant lesions in terms of tumor thickness and depth of invasion. The aim of the present protocol is to evaluate the role of intraoral ultra-high frequency ultrasonography in the study of oral mucosal lesions. conditions: Oral Squamous Cell Carcinoma studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: DIAGNOSTIC masking: NONE count: 400 type: ESTIMATED name: Ultrasound measure: Depth of invasion sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Università di Pisa status: RECRUITING city: Pisa zip: 56126 country: Italy name: Rossana Izzetti, DS, PhD role: CONTACT phone: +39050993037 email: rossana.izzetti@unipi.it lat: 43.70853 lon: 10.4036 hasResults: False
nctId: NCT06336928 id: 1B-23-6 id: NCI-2024-01332 type: REGISTRY domain: CTRP (Clinical Trial Reporting Program) id: 1B-23-6 type: OTHER domain: USC / Norris Comprehensive Cancer Center id: P30CA014089 type: NIH link: https://reporter.nih.gov/quickSearch/P30CA014089 briefTitle: A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2029-04-01 date: 2030-04-01 date: 2024-03-29 date: 2024-03-29 name: University of Southern California class: OTHER name: National Cancer Institute (NCI) briefSummary: This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer. conditions: Breast Carcinoma studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 490 type: ESTIMATED name: Non-Interventional Study measure: Assess the sensitivity and specificity of LBx as a screening method for breast cancer sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Keck Medicine of USC Koreatown city: Los Angeles state: California zip: 90020 country: United States name: Bomi Choi role: CONTACT phone: 323-865-0451 email: Bomi.Choi@med.usc.edu name: Anastasia Martynova, MD role: PRINCIPAL_INVESTIGATOR lat: 34.05223 lon: -118.24368 facility: Los Angeles General Medical Center city: Los Angeles state: California zip: 90033 country: United States name: Kimberly Arieli, RN role: CONTACT phone: 323-865-0451 email: Kimberly.Arieli@med.usc.edu name: Anastasia Martynova, MD role: PRINCIPAL_INVESTIGATOR lat: 34.05223 lon: -118.24368 facility: USC / Norris Comprehensive Cancer Center city: Los Angeles state: California zip: 90033 country: United States name: Kimberly Arieli, RN role: CONTACT phone: 323-865-0451 email: Kimberly.Arieli@med.usc.edu name: Anastasia Martynova, MD role: PRINCIPAL_INVESTIGATOR lat: 34.05223 lon: -118.24368 facility: USC Norris Oncology/Hematology-Newport Beach city: Newport Beach state: California zip: 92663 country: United States name: Kristy Massopust role: CONTACT phone: 949-474-5733 email: Massopust_K@med.usc.edu name: Anastasia Martynova, MD role: PRINCIPAL_INVESTIGATOR lat: 33.61891 lon: -117.92895 hasResults: False
nctId: NCT06336915 id: 121.NUR.2022.D briefTitle: Physician-Nurse Dyad Rounding: A Collaborative Approach to Improve Unit-Level Metrics overallStatus: RECRUITING date: 2023-01-03 date: 2024-12-30 date: 2024-12-30 date: 2024-03-29 date: 2024-03-29 name: Methodist Health System class: OTHER briefSummary: The project will be implemented on one unit at a time until the co-rounding process has been implemented on each Medical-Surgical unit. This study will involve the geo-localized hospitalist on the designated unit and the nursing staff involved in clinical patient care conditions: Wellness, Psychological studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: RETROSPECTIVE count: 300 type: ESTIMATED name: Physician-Nurse Dyad Rounding measure: Difference in percentage of discharged patients before 1400 (Mon-Fri) after project implementation compared to before implementation measure: Difference in Top Box Patient Satisfaction Scores and Doctor Domain measure: Difference in LOS of private hospitalist patients after project implementation compared to before implementation measure: Difference in collaboration and build positive relationships scores after project implementation compared to before implementation sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Clinical Research Institute at Methodist Health System status: RECRUITING city: Dallas state: Texas zip: 75203 country: United States name: Colette N Ndjom, MS role: CONTACT phone: 410-947-4681 phoneExt: 74681 email: ColetteNgoNdjom@mhd.com name: Loretta W Bedell, MPH role: CONTACT phone: 214-947-4680 phoneExt: 74680 email: lorettabedell@mhd.com name: Lauren Hoffman, MD role: PRINCIPAL_INVESTIGATOR lat: 32.78306 lon: -96.80667 facility: Methodist Dallas Medical Center status: NOT_YET_RECRUITING city: Dallas state: Texas zip: 75203 country: United States name: Colette N Ndjom, MS role: CONTACT phone: 214-947-4681 email: mhsirb@mhd.com name: Loretta W Bedell, MPH role: CONTACT phone: 217-947-4680 email: mhsirb@mhd.com name: Lauren Hoffman, MD role: PRINCIPAL_INVESTIGATOR lat: 32.78306 lon: -96.80667 hasResults: False
nctId: NCT06336889 id: 092.TRA.2018.D briefTitle: Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used) overallStatus: RECRUITING date: 2017-10-26 date: 2024-10 date: 2024-10 date: 2024-03-29 date: 2024-03-29 name: Methodist Health System class: OTHER briefSummary: The investigator's propose a multicenter prospective observational study to investigate the use of embolization in patients with negative angiogram and to ascertain the optimal level of treatment when the angiogram is positive; non-selective vs. selective embolization. conditions: Pelvic Hemorrhage studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 400 type: ESTIMATED name: Pelvic Angioembolization measure: Mortality outcome measure: transfusion requirements measure: thromboembolic events measure: Patient demographics(age, sex) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Methodist Dallas Medical Center status: RECRUITING city: Dallas state: Texas zip: 75201 country: United States name: Jennifer Burris, MD role: CONTACT phone: 214-947-1280 email: clinicalresearch@mhd.com lat: 32.78306 lon: -96.80667 hasResults: False